Expanding treatment options by selectively targeting the cytokine storm with ruxolitinib in primary hemophagocytic lymphohistiocytosis

MeSH terms

• Cytokine Release Syndrome* / drug therapy
• Cytokine Release Syndrome* / etiology
• Humans
• Lymphohistiocytosis, Hemophagocytic* / drug therapy
• Lymphohistiocytosis, Hemophagocytic* / etiology
• Nitriles
• Pyrazoles*
• Pyrimidines